Akari Therapeutics (CLA1) Cash flow

0 Followers

Akari Therapeutics Cash Flow

DE:CLA1's free cash flow for Q2 2026 was $-3.11M. For the 2026 fiscal year, DE:CLA1's free cash flow was decreased by $1.98M and operating cash flow was $-3.11M. See a summary of the company’s cash flow.

Cash Flow	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Operating Cash Flow	$ -10.57M	$ -12.55M	$ -16.43M	$ -21.50M	$ -18.85M
Investing Cash Flow	$ 0.00	$ 382.00K	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 13.17M	$ 10.99M	$ 7.02M	$ 25.29M	$ 14.29M
End Cash Position	$ 5.26M	$ 2.66M	$ 3.85M	$ 13.25M	$ 9.36M
Free Cash Flow	$ -10.57M	$ -12.55M	$ -16.43M	$ -21.50M	$ -18.85M

Currency in USD